These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 11959617)

  • 21. A multicenter evaluation of linezolid antimicrobial activity in North America.
    Ballow CH; Jones RN; Biedenbach DJ;
    Diagn Microbiol Infect Dis; 2002 May; 43(1):75-83. PubMed ID: 12052632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro efficacy and pharmacodynamic indices for antibiotics against coagulase-negative staphylococcus endophthalmitis isolates.
    Harper T; Miller D; Flynn HW
    Ophthalmology; 2007 May; 114(5):871-5. PubMed ID: 17383732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multicenter assessment of the linezolid spectrum and activity using the disk diffusion and Etest methods: report of the Zyvox(R) antimicrobial potency study in Latin America (LA-ZAPS).
    Ballow CH; Biedenbach DJ; Rossi F; Jones RN;
    Braz J Infect Dis; 2002 Jun; 6(3):100-9. PubMed ID: 12144745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metronidazole resistance in Clostridium difficile is heterogeneous.
    Peláez T; Cercenado E; Alcalá L; Marín M; Martín-López A; Martínez-Alarcón J; Catalán P; Sánchez-Somolinos M; Bouza E
    J Clin Microbiol; 2008 Sep; 46(9):3028-32. PubMed ID: 18650353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of tedizolid (TR-700) against linezolid-resistant staphylococci.
    Rodríguez-Avial I; Culebras E; Betriu C; Morales G; Pena I; Picazo JJ
    J Antimicrob Chemother; 2012 Jan; 67(1):167-9. PubMed ID: 21954458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activities of linezolid against multiple Nocardia species.
    Brown-Elliott BA; Ward SC; Crist CJ; Mann LB; Wilson RW; Wallace RJ
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1295-7. PubMed ID: 11257051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptibility testing of Clostridium difficile against metronidazole and vancomycin by disk diffusion and Etest.
    Wong SS; Woo PC; Luk WK; Yuen KY
    Diagn Microbiol Infect Dis; 1999 May; 34(1):1-6. PubMed ID: 10342100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial susceptibilities of Clostridium difficile isolated in Japan.
    Kunishima H; Chiba J; Saito M; Honda Y; Kaku M
    J Infect Chemother; 2013 Apr; 19(2):360-2. PubMed ID: 23338015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of sub-MIC concentrations of metronidazole, vancomycin, clindamycin and linezolid on toxin gene transcription and production in Clostridium difficile.
    Gerber M; Walch C; Löffler B; Tischendorf K; Reischl U; Ackermann G
    J Med Microbiol; 2008 Jun; 57(Pt 6):776-783. PubMed ID: 18480337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial susceptibility pattern of Clostridium difficile and its relation to PCR ribotypes in a Swedish university hospital.
    Aspevall O; Lundberg A; Burman LG; Akerlund T; Svenungsson B
    Antimicrob Agents Chemother; 2006 May; 50(5):1890-2. PubMed ID: 16641471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activities of linezolid, meropenem, and quinupristin-dalfopristin against group C and G streptococci, including vancomycin-tolerant isolates.
    Zaoutis T; Moore LS; Furness K; Klein JD
    Antimicrob Agents Chemother; 2001 Jul; 45(7):1952-4. PubMed ID: 11408207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clostridium difficile bacteremia, Taiwan.
    Lee NY; Huang YT; Hsueh PR; Ko WC
    Emerg Infect Dis; 2010 Aug; 16(8):1204-10. PubMed ID: 20678312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial activity of LFF571 and three treatment agents against Clostridium difficile isolates collected for a pan-European survey in 2008: clinical and therapeutic implications.
    Debast SB; Bauer MP; Sanders IM; Wilcox MH; Kuijper EJ;
    J Antimicrob Chemother; 2013 Jun; 68(6):1305-11. PubMed ID: 23420839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vitro susceptibility to linezolid in methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus strains].
    Efe S; Sinirtaş M; Ozakin C
    Mikrobiyol Bul; 2009 Oct; 43(4):639-43. PubMed ID: 20084917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity of AZD2563, a novel oxazolidinone, against Staphylococcus aureus strains with reduced susceptibility to vancomycin or linezolid.
    Howe RA; Wootton M; Noel AR; Bowker KE; Walsh TR; MacGowan AP
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3651-2. PubMed ID: 14576139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spectrum and potency evaluation of a new oxazolidinone, linezolid: report from the SENTRY Antimicrobial Surveillance Program, 1998-2000.
    Mutnick AH; Biedenbach DJ; Turnidge JD; Jones RN
    Diagn Microbiol Infect Dis; 2002 May; 43(1):65-73. PubMed ID: 12052631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of OPT-80 tested against clinical isolates of toxin-producing Clostridium difficile.
    Karlowsky JA; Laing NM; Zhanel GG
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4163-5. PubMed ID: 18725442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro analysis of resistance selection by linezolid in vancomycin-susceptible and -resistant Enterococcus faecalis and Enterococcus faecium.
    Allen GP; Bierman BC
    Int J Antimicrob Agents; 2009 Jul; 34(1):21-4. PubMed ID: 19243921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multicenter-based study on epidemiology, antibiotic susceptibility and risk factors of toxigenic Clostridium difficile in hospitalized patients in southwestern Iran.
    Sedigh Ebrahim-Saraie H; Heidari H; Amanati A; Bazargani A; Alireza Taghavi S; Nikokar I; Kalantar K; Motamedifar M
    Infez Med; 2018 Dec; 26(4):308-315. PubMed ID: 30555133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diversity of Circulating
    Martínez-Meléndez A; Tijerina-Rodríguez L; Collins N; Baines SD; Morfin-Otero R; Camacho-Ortíz A; Villarreal-Treviño L; Garza-González E
    Microb Drug Resist; 2021 Dec; 27(12):1672-1676. PubMed ID: 34037477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.